Patent ID: 8765166

Claim:
A device for insertion in the eye comprising: a composition in the form of a matrix of an active agent and a non-water soluble polymer, wherein the active agent is selected from the group consisting of latanoprost free acid salt, travoprost free acid salt, bimatoprost free acid salt, and tafluprost free acid salt; a first polymer portion; a second polymer portion fused to the first polymer portion, the second polymer portion including a recess configured to support the composition; and a third polymer portion fused to the second polymer portion, wherein the total thickness of the device ranges from 20 μm to 500 μm, and wherein the device is configured to: (a) conform to a curvature of the eye, (b) yield an elution rate of 0.00025-0.0075 micrograms/hr of the active agent, and (c) release 70% to 90% of the active agent over a period of at least 30 days.